Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 8/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 10/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21040574 | 0.81 | AKR1C3 (0.52) | AKR1C3APEX1TBXAS1RXRARXRB | |
| SCHEMBL21001877 | 0.81 | AKR1C3 (0.52) | AKR1C3APEX1TBXAS1RXRARXRB | |
| SCHEMBL21002161 | 0.81 | AKR1C3 (0.52) | AKR1C3APEX1TBXAS1RXRARXRB | |
| SCHEMBL17368451 | 0.78 | AKR1C3 (0.44) | AKR1C3APEX1TBXAS1RXRARXRB | |
| SCHEMBL27944360 | 0.71 | AKR1C3 (0.55) | AKR1C3APEX1TBXAS1RXRARXRB | |
| SCHEMBL7268646 | 0.67 | AKR1C3 (0.67) | AKR1C3TBXAS1 | |
| SCHEMBL7963228 | 0.67 | AKR1C3 (0.67) | AKR1C3TBXAS1 | |
| SCHEMBL27224536 | 0.67 | AKR1C3 (0.67) | AKR1C3TBXAS1 | |
| SCHEMBL2462984 | 0.66 | AKR1C3 (0.82) | AKR1C3APEX1TBXAS1 | |
| SCHEMBL8746653 | 0.66 | AKR1C3 (0.67) | AKR1C3APEX1TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2112189-B1 | (Meth)acrylic-modified siloxane compounds | SHINETSU CHEMICAL CO (JP) | 2012-02-22 | — | — | EP | claimed |
| US-11034178-B2 | Thermal transfer sheet | DAI NIPPON PRINTING CO., LTD. (JP) | 2021-06-15 | — | — | US | disclosed |
| EP-3434495-B1 | THERMAL TRANSFER SHEET | DAINIPPON PRINTING CO LTD (JP) | 2020-10-28 | — | — | EP | disclosed |
| US-20190143641-A1 | THERMAL TRANSFER SHEET | DAI NIPPON PRINTING CO., LTD. (JP) | 2019-05-16 | — | — | US | disclosed |
| EP-3434495-A1 | THERMAL TRANSFER SHEET | Dai Nippon Printing Co., Ltd. (JP) | 2019-01-30 | — | — | EP | disclosed |
| US-20180272779-A1 | TRANSFER FILM | DAI NIPPON PRINTING CO., LTD. (JP) | 2018-09-27 | — | — | US | disclosed |
| EP-3342603-A1 | TRANSFER FOIL | DAI NIPPON PRINTING CO., LTD. (JP) | 2018-07-04 | — | — | EP | disclosed |
| EP-3260296-A1 | TRANSFER FOIL | Dai Nippon Printing Co., Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-20140044891-A1 | OPTICAL LAMINATE | NITTO DENKO CORPORATION (JP) | 2014-02-13 | — | — | US | disclosed |
| US-8288493-B2 | (meth)acrylic-modified siloxane compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20090270529-A1 | (METH)ACRYLIC-MODIFIED SILOXANE COMPOUNDS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-10-29 | — | — | US | disclosed |
| US-7291400-B2 | Decorative sheet | DAI NIPPON PRINTING CO., LTD. (JP) | 2007-11-06 | — | — | US | disclosed |
| US-20050129970-A1 | Decorative sheet | DAI NIPPON PRINTING CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090270529-A1 | (METH)ACRYLIC-MODIFIED SILOXANE COMPOUNDS | MMAB, MGMT, PAM | AKR1C3 3115/4885APEX1 1120/4885TBXAS1 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.